Is Stage 1 Hypertension as Defined in ACC/AHA Guidelines Associated with Any Events?

New information has been published fast, and what we thought we knew about hypertension has also changed fast. One of the biggest differences between American and European hypertension guidelines is whether patients with systolic blood pressure (BP) 130/139 mmHg and diastolic BP 80/89 mmHg are considered hypertensive or not. The only place where enough patients with these levels could be found is China and, while a Chinese population is clearly different from a Latin America population, this work answered some of our questions.

¿Es seguro dar el alta el mismo día luego de una angioplastia?The effect of considering these patients as hypertensive as per American guidelines is observed in a reduction of cardiovascular risk among young or middle-aged patients, but no benefit is observed in patients ≥60 years old.

 

This work included 21,441 patients over 35 years old without cardiovascular disease at baseline for this registry. The follow-up was 20 years for the entire cohort and the risk of cardiovascular disease calculated could be attributed to the new stage 1 hypertension classification.


Read also: New European Hypertension Guidelines Contrast with American Recommendations.


The risk of cardiovascular disease for patients from 35 to 59 years old with stage 1 hypertension almost doubled the risk for people with BP <120/80 (hazard ratio [HR] for cardiovascular disease: 1.78; 95% confidence interval [CI]: 1.50 to 2.11). The increase in the specific risk of coronary disease was similar (HR: 1.77; 95% CI: 1.33 to 2.36), while the increase in the risk of stroke was somewhat higher (HR: 1.79; 95% CI: 1.45 to 2.22). The increase in the rate of cardiovascular death was more than double (HR: 2.50; 95% CI: 1.66 to 3.77), which is worrisome.

 

The proportions of cardiovascular death and events attributable to stage 1 hypertension among participants aged 35 to 59 years were 26.5% and 13.4%, respectively.

 

However, among participants aged ≥60 years, no higher risk was observed in patients with stage 1 hypertension compared with those with BP <120/80 mmHg.


Read also: New High Blood Pressure Guidelines.


Over 15 years, 65% of young patients with stage 1 hypertension evolved to 140/90 mmHg or higher, and their risk rates tripled compared with the remaining 35% who maintained a BP lower than 130/80 mmHg.

 

Conclusion

The effect of considering patients with BP between 130/139 and 80/89 mmHg (American College of Cardiology/American Heart Association [ACC/AHA] stage 1 hypertension) as hypertensive is observed only in young and middle-aged patients, while those aged ≥60 years did not evidence any association between these figures and cardiovascular risk.

 

Original title: Long-Term Cardiovascular Risk Associated with Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline.

Reference: Yue Qi et al. J Am Coll Cardiol 2018;72:1201-10.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which reflects in lower rates of target lesion...

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral anticoagulant (OAC) therapy. This creates a complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....